123 related articles for article (PubMed ID: 2448499)
1. Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis.
Fan K
J Urol; 1988 Feb; 139(2):318-22. PubMed ID: 2448499
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Epstein JI; Eggleston JC
Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
[TBL] [Abstract][Full Text] [Related]
3. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
Shah NT; Tuttle SE; Strobel SL; Gandhi L
J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
[TBL] [Abstract][Full Text] [Related]
4. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
[TBL] [Abstract][Full Text] [Related]
5. Expression of ras oncogene p21 in prostate cancer.
Viola MV; Fromowitz F; Oravez S; Deb S; Finkel G; Lundy J; Hand P; Thor A; Schlom J
N Engl J Med; 1986 Jan; 314(3):133-7. PubMed ID: 2417118
[TBL] [Abstract][Full Text] [Related]
6. Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
Rizk CC; Scholes J; Chen SK; Ward J; Romas NA
Urology; 1990 Dec; 36(6):526-30. PubMed ID: 1701066
[TBL] [Abstract][Full Text] [Related]
7. Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites.
Stein BS; Vangore S; Petersen RO
Urology; 1984 Aug; 24(2):146-52. PubMed ID: 6205496
[TBL] [Abstract][Full Text] [Related]
8. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
[TBL] [Abstract][Full Text] [Related]
9. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.
Warhol MJ; Longtine JA
J Urol; 1985 Sep; 134(3):607-13. PubMed ID: 2411954
[TBL] [Abstract][Full Text] [Related]
10. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
[TBL] [Abstract][Full Text] [Related]
11. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
12. Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques.
Mansi JL; Berger U; Wilson P; Shearer R; Coombes RC
J Urol; 1988 Mar; 139(3):545-8. PubMed ID: 2449548
[TBL] [Abstract][Full Text] [Related]
13. Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen.
Azumi N; Shibuya H; Ishikura M
Am J Surg Pathol; 1984 Jul; 8(7):545-50. PubMed ID: 6204547
[TBL] [Abstract][Full Text] [Related]
14. Histochemical study of R1881-binding protein, prostatic acid phosphatase, prostate-specific antigen, and r-seminoprotein in prostatic cancer.
Ito H; Yamaguchi K; Sumiya H; Matsuzaki O; Shimazaki J
Eur Urol; 1986; 12(1):49-53. PubMed ID: 2419136
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
Epstein JI; Woodruff JM
Cancer; 1986 Jan; 57(1):111-9. PubMed ID: 2416422
[TBL] [Abstract][Full Text] [Related]
16. Disseminated prostatic carcinoma simulating primary lung cancer. Indications for immunodiagnostic studies.
Gentile PS; Carloss HW; Huang TY; Yam LT; Lam WK
Cancer; 1988 Aug; 62(4):711-5. PubMed ID: 2456142
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
18. Predicting the probability of bone metastasis through histological grading of prostate carcinoma: a retrospective correlative analysis of 81 autopsy cases with antemortem transurethral resection specimen.
Fan K; Peng CF
J Urol; 1983 Oct; 130(4):708-11. PubMed ID: 6350620
[TBL] [Abstract][Full Text] [Related]
19. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
20. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]